Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 79 of 79 entries
Sorted by: Best Match Show Resources per page
One-year mental health outcomes in a cohort of COVID-19 survivors.

Journal of psychiatric research

Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F.
PMID: 34894521
J Psychiatr Res. 2021 Nov 22;145:118-124. doi: 10.1016/j.jpsychires.2021.11.031. Epub 2021 Nov 22.

COVID-19 survivors are at increased risk of persistent psychopathology after the infection. Despite long-term sequelae are an increasing concern, long-term neuropsychiatric consequences remain largely unclear. This cohort study aimed at investigating the psychopathological impact of COVID-19 in Italy one...

Cite
Mazza MG, Palladini M, De Lorenzo R, et al. One-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res. 2021;145:118-124doi: 10.1016/j.jpsychires.2021.11.031.
Mazza, M. G., Palladini, M., De Lorenzo, R., Bravi, B., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021). One-year mental health outcomes in a cohort of COVID-19 survivors. Journal of psychiatric research, 145118-124. https://doi.org/10.1016/j.jpsychires.2021.11.031
Mazza, Mario Gennaro, et al. "One-year mental health outcomes in a cohort of COVID-19 survivors." Journal of psychiatric research vol. 145 (2021): 118-124. doi: https://doi.org/10.1016/j.jpsychires.2021.11.031
Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F. One-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res. 2021 Nov 22;145:118-124. doi: 10.1016/j.jpsychires.2021.11.031. Epub 2021 Nov 22. PMID: 34894521; PMCID: PMC8607816.
Copy Download .nbib Format: NLM
One-year mental health outcomes in a cohort of COVID-19 survivors.

Journal of psychiatric research

Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F.
PMID: 34894521
J Psychiatr Res. 2021 Nov 22;145:118-124. doi: 10.1016/j.jpsychires.2021.11.031. Epub 2021 Nov 22.

COVID-19 survivors are at increased risk of persistent psychopathology after the infection. Despite long-term sequelae are an increasing concern, long-term neuropsychiatric consequences remain largely unclear. This cohort study aimed at investigating the psychopathological impact of COVID-19 in Italy one...

Cite
Mazza MG, Palladini M, De Lorenzo R, et al. One-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res. 2021;145:118-124doi: 10.1016/j.jpsychires.2021.11.031.
Mazza, M. G., Palladini, M., De Lorenzo, R., Bravi, B., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021). One-year mental health outcomes in a cohort of COVID-19 survivors. Journal of psychiatric research, 145118-124. https://doi.org/10.1016/j.jpsychires.2021.11.031
Mazza, Mario Gennaro, et al. "One-year mental health outcomes in a cohort of COVID-19 survivors." Journal of psychiatric research vol. 145 (2021): 118-124. doi: https://doi.org/10.1016/j.jpsychires.2021.11.031
Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F. One-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res. 2021 Nov 22;145:118-124. doi: 10.1016/j.jpsychires.2021.11.031. Epub 2021 Nov 22. PMID: 34894521.
Copy Download .nbib Format: NLM
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F.
PMID: 34634679
Eur Neuropsychopharmacol. 2022 Jan;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 09.

The spreading of the Severe Acute Respiratory Syndrome Coronavirus (COVID-19) pandemic could be associated with psychiatric implications. After COVID-19, depression was reported in 40% of patients at one-, three-, and six-months follow-up. Emerging literature suggests anti-inflammatory and antiviral properties...

Cite
Mazza MG, Zanardi R, Palladini M, et al. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2021;54:1-6doi: 10.1016/j.euroneuro.2021.09.009.
Mazza, M. G., Zanardi, R., Palladini, M., Rovere-Querini, P., & Benedetti, F. (2022). Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 541-6. https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza, Mario Gennaro, et al. "Rapid response to selective serotonin reuptake inhibitors in post-COVID depression." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 54 (2022): 1-6. doi: https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2022 Jan;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 09. PMID: 34634679; PMCID: PMC8500775.
Copy Download .nbib Format: NLM
Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)

Manfredi AA, Ramirez GA, Godino C, Capobianco A, Monno A, Franchini S, Tombetti E, Corradetti S, Distler JH, Bianchi ME, Rovere-Querini P, Maugeri N.
PMID: 34279048
Arthritis Rheumatol. 2021 Jul 19; doi: 10.1002/art.41926. Epub 2021 Jul 19.

OBJECTIVES: It is unclear why activated platelets and platelet-derived microparticles (µPs) accumulate in the blood of patients with systemic sclerosis (SSc). Here we investigated whether defective phagocytosis might contribute.METHODS: Platelet-neutrophil interaction, phagocytosis, P-selectin, PSGL-1, HMGB1 expression and distribution on...

Cite
Manfredi AA, Ramirez GA, Godino C, et al. Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis. Arthritis Rheumatol. 2021;doi: 10.1002/art.41926.
Manfredi, A. A., Ramirez, G. A., Godino, C., Capobianco, A., Monno, A., Franchini, S., Tombetti, E., Corradetti, S., Distler, J. H., Bianchi, M. E., Rovere-Querini, P., & Maugeri, N. (2021). Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis. Arthritis & rheumatology (Hoboken, N.J.), . https://doi.org/10.1002/art.41926
Manfredi, Angelo A, et al. "Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis." Arthritis & rheumatology (Hoboken, N.J.) vol. (2021). doi: https://doi.org/10.1002/art.41926
Manfredi AA, Ramirez GA, Godino C, Capobianco A, Monno A, Franchini S, Tombetti E, Corradetti S, Distler JH, Bianchi ME, Rovere-Querini P, Maugeri N. Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis. Arthritis Rheumatol. 2021 Jul 19; doi: 10.1002/art.41926. Epub 2021 Jul 19. PMID: 34279048.
Copy Download .nbib Format: NLM
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.

The Lancet. Rheumatology

Cavalli G, Larcher A, Tomelleri A, Campochiaro C, Della-Torre E, De Luca G, Farina N, Boffini N, Ruggeri A, Poli A, Scarpellini P, Rovere-Querini P, Tresoldi M, Salonia A, Montorsi F, Landoni G, Castagna A, Ciceri F, Zangrillo A, Dagna L.
PMID: 33655218
Lancet Rheumatol. 2021 Apr;3(4):e253-e261. doi: 10.1016/S2665-9913(21)00012-6. Epub 2021 Feb 03.

BACKGROUND: Patients with severe COVID-19 develop a life-threatening hyperinflammatory response to the virus. Interleukin (IL)-1 or IL-6 inhibitors have been used to treat this patient population, but the comparative effectiveness of these different strategies remains undetermined. We aimed to...

Cite
Cavalli G, Larcher A, Tomelleri A, et al. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021;3(4):e253-e261doi: 10.1016/S2665-9913(21)00012-6.
Cavalli, G., Larcher, A., Tomelleri, A., Campochiaro, C., Della-Torre, E., De Luca, G., Farina, N., Boffini, N., Ruggeri, A., Poli, A., Scarpellini, P., Rovere-Querini, P., Tresoldi, M., Salonia, A., Montorsi, F., Landoni, G., Castagna, A., Ciceri, F., Zangrillo, A., & Dagna, L. (2021). Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. The Lancet. Rheumatology, 3(4), e253-e261. https://doi.org/10.1016/S2665-9913(21)00012-6
Cavalli, Giulio, et al. "Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study." The Lancet. Rheumatology vol. 3,4 (2021): e253-e261. doi: https://doi.org/10.1016/S2665-9913(21)00012-6
Cavalli G, Larcher A, Tomelleri A, Campochiaro C, Della-Torre E, De Luca G, Farina N, Boffini N, Ruggeri A, Poli A, Scarpellini P, Rovere-Querini P, Tresoldi M, Salonia A, Montorsi F, Landoni G, Castagna A, Ciceri F, Zangrillo A, Dagna L. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021 Apr;3(4):e253-e261. doi: 10.1016/S2665-9913(21)00012-6. Epub 2021 Feb 03. PMID: 33655218; PMCID: PMC7906668.
Copy Download .nbib Format: NLM
Vitamin D Levels Are Associated With Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity.

The Journal of clinical endocrinology and metabolism

di Filippo L, Allora A, Doga M, Formenti AM, Locatelli M, Rovere Querini P, Frara S, Giustina A.
PMID: 34383926
J Clin Endocrinol Metab. 2022 Jan 01;107(1):e348-e360. doi: 10.1210/clinem/dgab599.

CONTEXT: A high prevalence of vitamin D (VD) deficiency in COVID-19 patients has been reported and hypothesized to increase COVID-19 severity likely because of its negative impact on immune and inflammatory responses. Furthermore, clear associations between hypovitaminosis D and...

Cite
di Filippo L, Allora A, Doga M, et al. Vitamin D Levels Are Associated With Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity. J Clin Endocrinol Metab. 2022;107(1):e348-e360doi: 10.1210/clinem/dgab599.
di Filippo, L., Allora, A., Doga, M., Formenti, A. M., Locatelli, M., Rovere Querini, P., Frara, S., & Giustina, A. (2022). Vitamin D Levels Are Associated With Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity. The Journal of clinical endocrinology and metabolism, 107(1), e348-e360. https://doi.org/10.1210/clinem/dgab599
di Filippo, Luigi, et al. "Vitamin D Levels Are Associated With Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity." The Journal of clinical endocrinology and metabolism vol. 107,1 (2022): e348-e360. doi: https://doi.org/10.1210/clinem/dgab599
di Filippo L, Allora A, Doga M, Formenti AM, Locatelli M, Rovere Querini P, Frara S, Giustina A. Vitamin D Levels Are Associated With Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity. J Clin Endocrinol Metab. 2022 Jan 01;107(1):e348-e360. doi: 10.1210/clinem/dgab599. PMID: 34383926; PMCID: PMC8385994.
Copy Download .nbib Format: NLM
Residual lung damage following ARDS in COVID-19 ICU survivors.

Acta anaesthesiologica Scandinavica

Compagnone N, Palumbo D, Cremona G, Vitali G, De Lorenzo R, Calvi MR, Del Prete A, Baiardo Redaelli M, Calamarà S, Belletti A, Steidler S, Conte C, Zangrillo A, De Cobelli F, Rovere-Querini P, Monti G.
PMID: 34758108
Acta Anaesthesiol Scand. 2021 Nov 10; doi: 10.1111/aas.13996. Epub 2021 Nov 10.

BACKGROUND: Coronavirus disease 2019 acute respiratory distress syndrome (COVID-19 ARDS) is a disease that often requires invasive ventilation. Little is known about COVID-19 ARDS sequelae. We assessed the mid-term lung status of COVID-19 survivors and investigated factors associated with...

Cite
Compagnone N, Palumbo D, Cremona G, et al. Residual lung damage following ARDS in COVID-19 ICU survivors. Acta Anaesthesiol Scand. 2021;doi: 10.1111/aas.13996.
Compagnone, N., Palumbo, D., Cremona, G., Vitali, G., De Lorenzo, R., Calvi, M. R., Del Prete, A., Baiardo Redaelli, M., Calamarà, S., Belletti, A., Steidler, S., Conte, C., Zangrillo, A., De Cobelli, F., Rovere-Querini, P., & Monti, G. (2021). Residual lung damage following ARDS in COVID-19 ICU survivors. Acta anaesthesiologica Scandinavica, . https://doi.org/10.1111/aas.13996
Compagnone, Nicola, et al. "Residual lung damage following ARDS in COVID-19 ICU survivors." Acta anaesthesiologica Scandinavica vol. (2021). doi: https://doi.org/10.1111/aas.13996
Compagnone N, Palumbo D, Cremona G, Vitali G, De Lorenzo R, Calvi MR, Del Prete A, Baiardo Redaelli M, Calamarà S, Belletti A, Steidler S, Conte C, Zangrillo A, De Cobelli F, Rovere-Querini P, Monti G. Residual lung damage following ARDS in COVID-19 ICU survivors. Acta Anaesthesiol Scand. 2021 Nov 10; doi: 10.1111/aas.13996. Epub 2021 Nov 10. PMID: 34758108; PMCID: PMC8652634.
Copy Download .nbib Format: NLM
Showing 73 to 79 of 79 entries